You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 5,541,293


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,541,293
Title: Consensus human leukocyte interferon
Abstract:Disclosed are analogs of human leukocyte interferon which predominantly include those amino acid residues which are common to all naturally-occurring human leukocyte interferon subtype amino acid sequences and which include, at one or more of those positions where there is no amino acid common to all subtypes, an amino acid which predominantly occurs at that position and in no event include any amino acid residue which is not extant in that position in at least one naturally-occurring subtype.
Inventor(s): Stabinsky; Yitzhak (Boulder, CO)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Application Number:07/472,328
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of United States Patent 5,541,293: A Comprehensive Guide

Introduction

United States Patent 5,541,293, titled "Consensus human interferons," is a significant patent in the field of biotechnology, particularly in the area of interferon research. This patent, granted to Stabinsky, describes the synthesis, cloning, and expression of consensus human interferons. Here, we will delve into the scope and claims of this patent, as well as the broader patent landscape it inhabits.

Background of the Patent

Invention Overview

The patent focuses on the development of consensus human interferons, which are proteins that play a crucial role in the immune system. These interferons are engineered to have optimal biological activity and stability, making them valuable for therapeutic applications[2].

Technical Field

The technical field of this patent is biotechnology, specifically the area of protein engineering and molecular biology. This field is highly competitive and has seen numerous patent applications over the years, making the landscape complex and densely populated.

Claim Scope and Analysis

Importance of Claim Scope

The claim scope in a patent application is critical as it defines the boundaries of the invention and the protection it receives. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate[3].

Claims in US Patent 5,541,293

The claims in this patent are directed towards the specific embodiments of consensus human interferons, including their synthesis, cloning, and expression methods. The claims must be anchored to the embodiments disclosed in the specification to avoid being overly broad and risking invalidation.

Claim Construction

The claims are constructed to cover the specific consensus sequences of human interferons, the methods for producing these proteins, and their use in therapeutic applications. For example, Claim 1 might describe the consensus human interferon protein itself, while subsequent claims might detail the cloning and expression vectors used to produce it.

Risks of Overly Broad Claims

Overly broad claims can lead to invalidation on grounds such as the abstract idea exception or failure to meet the written description requirement. It is crucial that the claims are tailored to the specific embodiments disclosed in the patent specification to ensure validity and enforceability[3].

Patent Landscape Analysis

Prior Art

The patent landscape for interferons is dense with prior art. Conducting a thorough prior art search is essential to ensure that the claims in US Patent 5,541,293 are novel and non-obvious. Resources such as the USPTO's Patent Public Search tool, Global Dossier, and international patent databases like those provided by the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO) are invaluable for this purpose[1].

Related Patents

Other patents in the field of interferon research can provide insights into the competitive landscape. For instance, patents like EP1019515A1, which also deal with fusion proteins and interferons, can highlight areas of overlap and differentiation[2].

Global Patent Family

Using tools like Global Dossier, one can identify the patent family for US Patent 5,541,293, including related applications filed in other jurisdictions. This helps in understanding the global protection and any variations in claim scope across different countries[1].

Search and Analysis Tools

USPTO Resources

The USPTO offers several tools for patent searching, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. This tool provides enhanced access to prior art and is crucial for conducting preliminary patent searches[1].

International Databases

Databases from other international intellectual property offices, such as the EPO's esp@cenet and WIPO's PATENTSCOPE, provide access to global patent collections. These resources are essential for a comprehensive patent landscape analysis[1].

Derwent Innovations Index

The Derwent Innovations Index, accessible through Web of Science, is another powerful tool for global patent search and analysis. It covers over 100 million patent records from 95 issuing organizations, making it a valuable resource for detailed patent landscape analysis[4].

Legal and Regulatory Considerations

Patent Validity and Enforcement

The validity and enforceability of US Patent 5,541,293 depend on the accuracy and specificity of its claims. Ensuring that the claims are well-supported by the specification and do not infringe on prior art is crucial for maintaining patent validity[3].

International Protection

For global protection, the patent must be filed in various jurisdictions. The Global Dossier service helps in managing related applications across different IP offices, ensuring consistent protection and facilitating the patent granting process[1].

Industry Impact and Applications

Therapeutic Applications

The consensus human interferons described in US Patent 5,541,293 have significant therapeutic potential, particularly in treating viral infections and certain types of cancer. The patent's claims cover not only the proteins themselves but also their production and use in medical treatments[2].

Market Competition

The biotechnology market is highly competitive, with numerous companies and research institutions working on interferon-based therapies. The patent landscape analysis helps in understanding the competitive positioning of US Patent 5,541,293 and identifying potential areas for innovation and differentiation.

Conclusion

Understanding the scope and claims of US Patent 5,541,293 is essential for navigating the complex patent landscape in the biotechnology sector. By analyzing the claim scope, conducting thorough prior art searches, and utilizing various patent search tools, one can ensure the validity and enforceability of this patent. The therapeutic applications of consensus human interferons make this patent a significant player in the field of biotechnology.

Key Takeaways

  • Claim Scope: The claim scope must be balanced between being broad enough to offer protection and specific enough to avoid invalidation.
  • Prior Art Search: Conducting a thorough prior art search is crucial to ensure novelty and non-obviousness.
  • Global Protection: Managing related applications across different IP offices is essential for global protection.
  • Therapeutic Applications: The patent has significant therapeutic potential, particularly in treating viral infections and certain types of cancer.
  • Market Competition: The biotechnology market is highly competitive, and understanding the patent landscape is key to competitive positioning.

FAQs

Q: What is the main focus of US Patent 5,541,293?

A: The main focus of US Patent 5,541,293 is the synthesis, cloning, and expression of consensus human interferons.

Q: Why is claim scope important in a patent application?

A: Claim scope is important because it defines the boundaries of the invention and the protection it receives. Overly broad claims can be difficult to get granted and easier to invalidate.

Q: What tools can be used for conducting a prior art search for US Patent 5,541,293?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, and international databases like esp@cenet and PATENTSCOPE can be used for conducting a prior art search.

Q: How does the Global Dossier service help in managing patent applications?

A: The Global Dossier service helps in managing related applications across different IP offices, providing access to file histories, classification, and citation data, and facilitating the patent granting process.

Q: What are the therapeutic applications of the consensus human interferons described in US Patent 5,541,293?

A: The consensus human interferons have therapeutic potential in treating viral infections and certain types of cancer.

Sources

  1. USPTO: "Search for patents - USPTO"
  2. Google Patents: "EP1019515A1 - Fusion proteins comprising an ... - Google Patents"
  3. Rimon Law: "The Importance of Getting the Claim Scope Right in a US Patent Application"
  4. Duke University Libraries: "Finding Patents Online - Research Guides - Duke University"

More… ↓

⤷  Subscribe

Details for Patent 5,541,293

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Kadmon Pharmaceuticals Llc INFERGEN interferon alfacon-1 Injection 103663 October 06, 1997 ⤷  Subscribe 2002-05-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.